SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-004879
Filing Date
2020-05-01
Accepted
2020-05-01 08:31:35
Documents
54
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20200331x10q.htm 10-Q 1153423
2 EX-31.1 glyc-20200331ex3114f96db.htm EX-31.1 18155
3 EX-31.2 glyc-20200331ex312ad74d3.htm EX-31.2 17232
4 EX-32.1 glyc-20200331ex321fb2fe3.htm EX-32.1 10289
  Complete submission text file 0001558370-20-004879.txt   4168264

Data Files

Seq Description Document Type Size
5 EX-101.INS glyc-20200331.xml EX-101.INS 793230
6 EX-101.SCH glyc-20200331.xsd EX-101.SCH 28828
7 EX-101.CAL glyc-20200331_cal.xml EX-101.CAL 36949
8 EX-101.DEF glyc-20200331_def.xml EX-101.DEF 122691
9 EX-101.LAB glyc-20200331_lab.xml EX-101.LAB 269575
10 EX-101.PRE glyc-20200331_pre.xml EX-101.PRE 234692
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 20838515
SIC: 2834 Pharmaceutical Preparations